Skip to main content

Silk Road Medical to Present at Upcoming Investor Conferences

 SUNNYVALE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) --  Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that management will present at the following investor conferences.

  • Stifel 2022 Healthcare Conference

Presentation on Tuesday, November 15 at 10:20 a.m. Eastern Time

  • 4th Annual Wolfe Research Healthcare Conference

Presentation on Wednesday, November 16 at 1:20 p.m. Eastern Time

  • 34th Annual Piper Sandler Healthcare Conference

Presentation on Wednesday, November 30 at 3:00 p.m. Eastern Time

Interested parties may access a live and archived webcast of each presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/.

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com

Media:
Michael Fanucchi
Silk Road Medical
mfanucchi@silkroadmed.com


Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.